Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 4,201-4,212 of 4,306
Other study type icon
Not recruitingISRCTN36607067

Pharmacological treatment of psychotic depression

This study is looking at whether Trial treatments: 1 can help people with In- with psychotic depression, Mental and Behavioural Disorders, or Depression. Participants receive a study treatment and complete follow-up visits and assessments.

In Netherlands
Why is this study shown?

This study includes Schizophrenia among several conditions.

Depression, SchizophreniaOtherOver 18 Years
Countries
Netherlands
Sponsor
University Medical Center Utrecht (UMCU) (The Netherlands)
Condition
Depression, Schizophrenia
Other study type icon
Not recruitingISRCTN97160532

SMRI-02T-162A: double blind placebo controlled study of a protein kinase C inhibitor: tamoxifen citrate in treatment of acute mania

This study is not recruiting in the United States and in Türkiye. It focuses on Bipolarity.

In Turkey
Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, SchizophreniaOtherOver 18 Years
Countries
United States, Türkiye
Sponsor
The Stanley Medical Research Institute (SMRI) (USA)
Condition
Bipolarity, Schizophrenia
Drug study icon
CompletedNCT04132557

A Study on Suicide prevention, Psychosis or Substance Abuse With Methylphenidate, Atomoxetine, Amphetamine/Dextroamphetamine or Lisdexamfetamine

This summary needs review. Please check the official study record and contact the research team for details.

In Titusville
Why is this study shown?

This study includes Schizophrenia among several conditions.

Suicidality, SchizophreniaDrugA study involving a medication or substance.
Countries
United States
Sponsor
Janssen Research & Development, LLC
Condition
Suicidality, Schizophrenia
Drug study icon
CompletedEUCTR 2013-002228-18

A randomized controlled clinical trial for assessing the effectiveness of pharmacogenetic information obtained with NEUROFARMAGEN in the treatment of patients with mental disorders

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Spain
Why is this study shown?

This study includes Schizophrenia among several conditions.

Depression, OCD, ...Drug
Countries
Spain
Sponsor
AB-BIOTICS S.A.
Condition
Depression, OCD, ...
Drug study icon
CompletedEUCTR 2004-002156-34

Double-blind, placebo-controlled trial investigating the safety of re-exposure to 900 mg of Org 34517, used as adjunctive therapy in subjects with psychotic major depression (major depressive episo...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Czech Republic
Why is this study shown?

This study includes Schizophrenia among several conditions.

Depression, SchizophreniaDrug
Countries
Czechia
Sponsor
NV Organon
Condition
Depression, Schizophrenia
Drug study icon
CompletedEUCTR 2011-003466-33

Memantine Add-On Therapy to Clozapine

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Netherlands
Why is this study shown?

This study includes Schizophrenia among several conditions.

Depression, SchizophreniaDrug
Countries
Netherlands
Sponsor
Mental Health Services North Holland North
Condition
Depression, Schizophrenia
Drug study icon
CompletedEUCTR 2004-000050-23

Prospective, double-blind, randomized, placebo-controlled dose finding study of the efficacy and safety of 2 target doses of Org 34517 used as adjunctive therapy in subjects with psychotic major de...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Czech Republic
Why is this study shown?

This study includes Schizophrenia among several conditions.

Depression, SchizophreniaDrug
Countries
United Kingdom, Czechia
Sponsor
NV Organon
Condition
Depression, Schizophrenia
Drug study icon
Recruitment unclearEUCTR 2007-000137-19

Metyrapone as additive treatment in patients with major depression

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Netherlands
Why is this study shown?

This study includes Schizophrenia among several conditions.

Depression, SchizophreniaDrug
Countries
Netherlands
Sponsor
Leiden University Medical Center
Condition
Depression, Schizophrenia
Drug study icon
Recruitment unclearEUCTR 2008-000041-60

Quetiapine in the treatment of psychotic depression. A pilot study (QTP-Dep-Bo)

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany
Why is this study shown?

This study includes Schizophrenia among several conditions.

Depression, SchizophreniaDrug
Countries
Germany
Sponsor
LWL Universitätsklinik für Psychiatrie Bochum
Condition
Depression, Schizophrenia
Drug study icon
Not recruitingEUCTR 2009-012003-26

Evaluation of Growth, Sexual Maturation, and Prolactin-Related Adverse Events in the Pediatric Population Exposed to Atypical Antipsychotic Drugs

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Belgium
Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, SchizophreniaDrug
Countries
Belgium, Greece, Netherlands
Sponsor
Janssen-Cilag International, NV
Condition
Bipolarity, Schizophrenia
Other study type icon
Not recruitingISRCTN60175188

The cognition game study

This study is looking at whether a digital support tool can help people with Cognitive impairment in psychiatric (we included subjects with schizophrenia/schizo-affective disorder, depression and OCD or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

In Netherlands
Why is this study shown?

This study includes Schizophrenia among several conditions.

Depression, OCD, ...Other
Countries
Netherlands
Sponsor
MyCognition
Condition
Depression, OCD, ...
Other study type icon
CompletedNCT00163865

A Study of Boredom in a Community Sample of Adolescents and a Clinical Sample of Adolescents

This summary needs review. Please check the official study record and contact the research team for details.

In Melbourne
Why is this study shown?

This study includes Schizophrenia among several conditions.

Anxiety, SchizophreniaObservationalA study where researchers collect information without assigning a treatment.From 13 Years to 18 Years
Countries
Australia
Sponsor
Bayside Health
Condition
Anxiety, Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.